secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2022-04-22T23:59:59+00:00
Accession:  0001104659-22-048968
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio appoints Eliot M. Lurier as Interim CFO via Danforth Advisors
-------------------------------------------------------------------------

- Eliot M. Lurier, age 63, appointed Interim CFO effective April 18, 2022; he is a consultant from Danforth Advisors.
- Lurier will serve as principal financial officer under a consulting agreement with Danforth; he receives no direct compensation from Mustang.
- Prior to Danforth, Lurier was CFO of Joslin Diabetes Center (2014-2020); he holds a B.S. in Accounting and is a CPA.
- No family relationships or transactions requiring disclosure exist between Lurier and Mustang's directors or officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465922048968/0001104659-22-048968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465922048968/tm2213050d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-048968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer